#FluVaccine

In a surprising turn that challenges long-standing public health directives, a study by the Cleveland Clinic has revealed that the influenza vaccine meant to combat the 2024-2025 flu season may have inadvertently increased the risk of infection among recipients. Conducted under the leadership of Dr. Nabin Shrestha, the research analyzed the health records of over 53,000 employees from the clinic’s Ohio locations, finding a 27% higher infection risk for those vaccinated compared to their unvaccinated counterparts source.